ORMP
Oramed Pharmaceuticals Inc
4.80$
+1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.0 | 11.5 | 5.2 | 22.0 | – | – | – | 2.5 | 1.8 | 1.3 | 1.2 | |
| 66.3 | 64.4 | 47.4 | 47.4 | 57.4 | 52.2 | 38.3 | 43.9 | 34.9 | 20.8 | 24.4 | 23.8 | 20.7 | 33.6 | 19.7 | 30.0 | 21.0 | 36.8 | 102.0 | 148.5 | 243.6 | 194.0 | 124.4 | 66.2 | 94.3 | 173.4 | 32.6 | 53.6 | 52.0 | 69.3 | 178.8 | – | – | – | 43.3 | 49.0 | 55.6 | 58.7 | – | – | |
| 3.7 | 3.4 | 3.9 | 5.2 | 7.3 | 5.6 | 4.6 | 6.5 | 2.7 | 1.8 | 2.5 | 2.9 | 2.9 | 5.3 | 3.3 | 2.4 | 1.7 | 3.5 | 5.6 | 5.9 | 5.7 | 3.1 | 2.1 | 1.2 | 1.7 | 3.1 | 0.6 | 1.0 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 32.5 | 17.5 | 26.6 | 13.9 | 31.4 | 89.5 | 127.3 | 215.1 | 182.3 | 114.2 | 55.2 | 82.0 | 158.5 | 23.8 | 51.2 | 86.7 | 100.8 | 199.2 | – | – | – | 6.1 | 41.2 | 29.7 | 35.8 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.3 | – | – | – | – | 0.9 | 1.1 | 2.0 | 1.2 | |
| 20.7 | 9.6 | 26.2 | 34.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.8% | 10.4% | 3.8% | 2.9% | -4.3% | -8.0% | -11.5% | -11.4% | -16.7% | -30.0% | -22.4% | -22.4% | -23.7% | -13.3% | -26.0% | -16.3% | -22.4% | -16.2% | -5.8% | -4.6% | -3.3% | -4.3% | -8.5% | -17.5% | -10.7% | -6.0% | -27.3% | -12.7% | -15.9% | -11.0% | -4.9% | -1.2% | -8.0% | -8.8% | -12.1% | -16.4% | -9.9% | -8.0% | -6.1% | -2.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 85.1% | 89.2% | 91.5% | 92.4% | 100.0% | 100.0% | 96.5% | 96.5% | 95.2% | 93.2% | 96.6% | 96.7% | 98.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | -6.2% | -5.0% | -4.0% | -3.9% | – | – | |
| -688.9% | -796.1% | -657.0% | -522.9% | -438.6% | -452.0% | -442.9% | -540.0% | -552.3% | -614.5% | -617.4% | -584.9% | -541.3% | -459.5% | -475.4% | -409.0% | -433.8% | -559.2% | -591.9% | -734.2% | -896.2% | -978.8% | -1,214.5% | -1,414.1% | -1,443.5% | -1,502.0% | -1,278.4% | -996.2% | -1,070.4% | -1,176.8% | -2,006.4% | – | – | – | -716.0% | -683.7% | -650.6% | -754.4% | – | – | |
| -754.6% | -896.1% | -723.9% | -572.5% | -426.7% | -422.3% | -412.6% | -510.1% | -519.7% | -577.1% | -593.7% | -568.4% | -531.1% | -466.0% | -464.1% | -398.3% | -424.8% | -536.5% | -572.3% | -680.5% | -822.7% | -908.5% | -1,123.3% | -1,323.7% | -1,339.1% | -1,359.7% | -1,040.6% | -695.1% | -730.2% | 531.5% | 1,551.3% | – | – | – | -1,411.9% | -1,208.1% | 2,192.6% | 3,202.5% | – | – | |
| 319.8% | 670.9% | 180.9% | 137.6% | -246.7% | -418.6% | -442.3% | -501.4% | -582.9% | -624.5% | -546.3% | -533.3% | -489.2% | -447.1% | -513.0% | -489.1% | -470.1% | -597.9% | -593.4% | -682.8% | -808.4% | -824.6% | -1,059.0% | -1,155.1% | -1,005.1% | -1,040.0% | -888.3% | -682.0% | -829.1% | -759.6% | -876.7% | – | – | – | -523.7% | -805.9% | -551.4% | -467.3% | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -41.9% | -46.7% | -59.0% | -63.3% | -54.5% | -45.6% | -49.4% | -75.0% | -40.9% | -50.2% | -60.3% | -69.6% | -74.0% | -73.4% | -78.2% | -31.6% | -35.0% | -51.5% | -31.3% | -27.0% | -19.2% | -14.4% | -18.7% | -23.2% | -23.5% | -24.2% | -18.6% | -12.4% | -9.9% | 4.3% | 6.3% | 11.8% | 2.9% | -13.0% | -20.1% | -15.6% | 21.6% | 32.1% | 46.2% | 55.1% | |
| -25.6% | -25.0% | -30.1% | -31.5% | -27.1% | -25.0% | -26.4% | -36.1% | -26.9% | -33.3% | -36.6% | -40.1% | -41.4% | -40.4% | -42.1% | -23.4% | -25.8% | -35.5% | -25.1% | -22.8% | -17.4% | -13.5% | -17.6% | -22.0% | -22.0% | -22.7% | -17.6% | -12.0% | -6.4% | 3.2% | 5.1% | 11.3% | 2.7% | -12.3% | -19.1% | -14.9% | 19.9% | 27.7% | 40.9% | 47.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3.1 | -5.9 | -9.3 | -19 | -15 | -34 | -57 | -77 | -32 | -28 | -30 | -33 | -40 | -24 | -6.5 | 70 | 42 | 14 | -85 | -42 | -54 | -74 | -16 | -52 | -46 | -13 | -15 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -11.9 | – | – | – | – | -0.8 | -0.7 | -0.2 | -0.1 | |
| 61.1% | 53.4% | 51.0% | 49.8% | 49.7% | 54.7% | 53.5% | 48.1% | 65.6% | 66.2% | 60.6% | 57.6% | 55.9% | 55.1% | 53.8% | 73.9% | 73.7% | 68.9% | 80.2% | 84.6% | 90.4% | 93.3% | 94.3% | 94.7% | 93.5% | 93.9% | 94.5% | 96.9% | 64.6% | 74.3% | 81.8% | 96.1% | 94.8% | 94.2% | 95.4% | 95.6% | 92.2% | 86.5% | 88.6% | 85.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.83 | -0.85 | -0.95 | -0.94 | -0.74 | -0.73 | -0.70 | -0.86 | -0.73 | -0.83 | -0.88 | -0.86 | -0.82 | -0.72 | -0.71 | -0.46 | -0.53 | -0.61 | -0.57 | -0.61 | -0.74 | -0.67 | -0.79 | -0.92 | -0.92 | -0.94 | -0.70 | -0.47 | -0.36 | 0.18 | 0.25 | 0.50 | 0.11 | -0.48 | -0.68 | -0.57 | 1.03 | 1.58 | 2.62 | 4.11 | |
| 0.11 | 0.09 | 0.13 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.12 | 0.12 | 0.11 | 0.10 | 0.09 | 0.09 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.05 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.05 | 0.05 | 0.00 | 0.00 | |
| 1.98 | 1.82 | 1.61 | 1.49 | 1.35 | 1.60 | 1.42 | 1.15 | 1.78 | 1.65 | 1.45 | 1.23 | 1.11 | 0.98 | 0.90 | 1.47 | 1.50 | 1.19 | 1.83 | 2.28 | 3.87 | 4.64 | 4.20 | 3.96 | 3.93 | 3.89 | 3.77 | 3.77 | 3.69 | 4.06 | 4.01 | 4.26 | 3.83 | 3.66 | 3.42 | 3.63 | 4.75 | 4.94 | 5.68 | 7.47 | |
| 0.35 | 0.64 | 0.24 | 0.23 | -0.43 | -0.72 | -0.75 | -0.85 | -0.82 | -0.90 | -0.81 | -0.81 | -0.76 | -0.69 | -0.78 | -0.57 | -0.58 | -0.68 | -0.59 | -0.62 | -0.73 | -0.61 | -0.74 | -0.80 | -0.69 | -0.72 | -0.60 | -0.46 | -0.41 | -0.25 | -0.14 | -0.03 | -0.19 | -0.21 | -0.25 | -0.38 | -0.26 | -0.23 | -0.21 | -0.13 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.